CADENCE PHARMACEUTICALS INC
DelistedCIK 1333248fmd_03XVBM18YMRXZABDYDQTRKAHV3Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Dec 31, 2013, 16 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 |
|---|---|---|---|---|---|
| Total revenues | – | – | 17 | 50 | 113 |
| Cost of revenue | – | – | 12 | 23 | 38 |
| Gross profit | – | – | 4 | 27 | 75 |
| Research and development | 19 | 14 | 9 | 7 | 7 |
| Selling, general and administrative | 25 | 39 | 82 | 87 | 94 |
| Operating income | (44) | (55) | (89) | (77) | (28) |
| Interest expense | 1 | 2 | 4 | 4 | 4 |
| Interest and investment income | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | (1) | (2) | (4) | (4) | 3 |
| Income before taxes | (45) | (57) | (93) | (81) | (24) |
| Net income | (45) | (57) | (93) | (81) | (24) |